216 related articles for article (PubMed ID: 21144483)
1. [Intranasal delivery of systemic drugs: a new route for opioid drugs].
Devillier P; Grassin-Delyle S; Naline E; Buenestado A; Blouquit-Laye S; Advenier C
Therapie; 2010; 65(5):475-81. PubMed ID: 21144483
[TBL] [Abstract][Full Text] [Related]
2. Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids.
Grassin-Delyle S; Buenestado A; Naline E; Faisy C; Blouquit-Laye S; Couderc LJ; Le Guen M; Fischler M; Devillier P
Pharmacol Ther; 2012 Jun; 134(3):366-79. PubMed ID: 22465159
[TBL] [Abstract][Full Text] [Related]
3. [Intranasal opioids for acute pain].
Añez Simón C; Rull Bartomeu M; Rodríguez Pérez A; Fuentes Baena A
Rev Esp Anestesiol Reanim; 2006 Dec; 53(10):643-52. PubMed ID: 17302079
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.
Foster D; Upton R; Christrup L; Popper L
Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103
[TBL] [Abstract][Full Text] [Related]
5. Intranasal fentanyl: from pharmacokinetics and bioavailability to current treatment applications.
Panagiotou I; Mystakidou K
Expert Rev Anticancer Ther; 2010 Jul; 10(7):1009-21. PubMed ID: 20645689
[TBL] [Abstract][Full Text] [Related]
6. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
7. Intranasal fentanyl for acute pain: techniques to enhance efficacy.
Wolfe T
Ann Emerg Med; 2007 May; 49(5):721-2. PubMed ID: 17452275
[No Abstract] [Full Text] [Related]
8. Impact of allergic rhinitis and its treatment on the pharmacokinetics of nasally administered fentanyl.
Perelman M; Fisher AN; Smith A; Knight A
Int J Clin Pharmacol Ther; 2013 May; 51(5):349-56. PubMed ID: 23458227
[TBL] [Abstract][Full Text] [Related]
9. Intranasal therapy with opioids for children and adolescents with cancer: results from clinical studies.
Triarico S; Capozza MA; Mastrangelo S; Attinà G; Maurizi P; Ruggiero A
Support Care Cancer; 2019 Oct; 27(10):3639-3645. PubMed ID: 31154533
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary delivery of opioids as pain therapeutics.
Farr SJ; Otulana BA
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1076-88. PubMed ID: 17070614
[TBL] [Abstract][Full Text] [Related]
11. Recent trends in drug delivery systems: intranasal drug delivery.
Agarwal V; Mishra B
Indian J Exp Biol; 1999 Jan; 37(1):6-16. PubMed ID: 10355359
[TBL] [Abstract][Full Text] [Related]
12. Faster absorption and higher systemic bioavailability of intranasal fentanyl spray compared to oral transmucosal fentanyl citrate in healthy subjects.
Nave R; Schmitt H; Popper L
Drug Deliv; 2013; 20(5):216-23. PubMed ID: 23650968
[TBL] [Abstract][Full Text] [Related]
13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of systemic and CNS delivery of meptazinol hydrochloride by intranasal administration to rats.
Shi ZQ; Zhang QZ; Jiang XG
Yao Xue Xue Bao; 2005 Aug; 40(8):754-7. PubMed ID: 16268513
[TBL] [Abstract][Full Text] [Related]
15. Fentanyl nasal spray for the treatment of cancer pain.
Mystakidou K; Panagiotou I; Gouliamos A
Expert Opin Pharmacother; 2011 Jul; 12(10):1653-9. PubMed ID: 21609189
[TBL] [Abstract][Full Text] [Related]
16. [Understanding Oral and Nasal Mucosal Absorption of Fentanyl, and Rectal Absorption of Buprenorphine].
Shimoyama N; Shimoyama M; Kubota Y; Kato Y
Masui; 2015 Nov; 64(11):1160-5. PubMed ID: 26689067
[TBL] [Abstract][Full Text] [Related]
17. [Oral transmucosal fentanyl citrate (OTFC) in the treatment of breakthrough pain].
Borgbjerg FM; Rosenberg J
Ugeskr Laeger; 2000 Sep; 162(39):5237-40. PubMed ID: 11043058
[TBL] [Abstract][Full Text] [Related]
18. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
Fortuna A; Alves G; Serralheiro A; Sousa J; Falcão A
Eur J Pharm Biopharm; 2014 Sep; 88(1):8-27. PubMed ID: 24681294
[TBL] [Abstract][Full Text] [Related]
19. Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients.
Solassol I; Caumette L; Bressolle F; Garcia F; Thézenas S; Astre C; Culine S; Coulouma R; Pinguet F
Oncol Rep; 2005 Oct; 14(4):1029-36. PubMed ID: 16142368
[TBL] [Abstract][Full Text] [Related]
20. Enhanced analgesic responses after preferential delivery of morphine and fentanyl to the olfactory epithelium in rats.
Hoekman JD; Ho RJ
Anesth Analg; 2011 Sep; 113(3):641-51. PubMed ID: 21709146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
